Sustained Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in SIV-Infected Macaques Correlates with Delayed Progression to AIDS
- 1 November 2002
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 18 (16) , 1197-1205
- https://doi.org/10.1089/08892220260387940
Abstract
Although several in vitro lines of evidence support the potential power of antibody-dependent cell-mediated cytotoxicity (ADCC) in controlling HIV infection, the role of ADCC in the pathogenesis of HIV infection in vivo remains uncertain. There are few studies to date that longitudinally determine the plasma ADCC activity in HIV-infected subjects. We sought to establish an SIV/macaque model to perform such a longitudinal study. In the rhesus macaque cohort studied here, three of five macaques (designated Group 1) maintained higher plasma ADCC activity for at least 1 year after inoculation with SIV/17E-Br. The ADCC activity of the two remaining macaques (Group 2) fell 12 weeks after inoculation. There were also differences in longitudinal measurements of anti-SIV envelope IgG titers and CD4 counts. Group 1 macaques maintained higher antienvelope IgG titers and higher CD4(+) T cell numbers as late as 60 weeks postinoculation, while Group 2 macaques had significantly lower titers at 1 year postinoculation and lower CD4(+) T cell counts by 30 weeks postinoculation. Our study shows a correlation between humoral response, ADCC activity, and disease progression (as measured by CD4(+) T cell counts). In these animals, ADCC activity is associated with delayed progression to AIDS. Further studies are underway to determine if ADCC is a protective immune response in SIV infection or if ADCC is a marker of intact cellular and humoral immune responses.Keywords
This publication has 28 references indexed in Scilit:
- Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4+Lymphocyte CountAIDS Research and Human Retroviruses, 2001
- Antibody-Dependent Cell-Mediated Cytotoxicity Can Protect PBMC from Infection by Cell-Associated HIV-1Clinical Immunology, 1999
- Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: comparison of humans and chimpanzeesAIDS, 1996
- Lysis of uninfected HIV-1 gp120-coated peripheral blood-derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicityFEMS Immunology & Medical Microbiology, 1995
- Immune Responses Induced by Prototype Vaccines for AIDS in Rhesus MonkeysAIDS Research and Human Retroviruses, 1994
- Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their childrenClinical and Experimental Immunology, 1993
- Primary Cytotoxicity against the Envelope Glycoprotein of Human Immunodeficiency Virus-It Evidence for Antibody-Dependent Cellular Cytotoxicity In VivoThe Journal of Infectious Diseases, 1990
- Antibodies Mediating Cellular Cytotoxicity and Neutralization Correlate with a Better Clinical Stage in Children Born to Human Immunodeficiency Virus-Infected MothersThe Journal of Infectious Diseases, 1990
- Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progressionJournal of Clinical Immunology, 1989
- Antibody-Dependent Cellular Cytotoxicity Specific for the Envelope Antigens of Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988